Background: Primary pulmonary choriocarcinoma (PPC) is a highly malignant intrapulmonary tumor with a notorious prognosis. Few clinical studies have been undertaken to investigate the clinical characteristics and prognosis of PPC. Material and methods: We systematically conducted a retrospective analysis of patients with PPC in the literature published in PubMed and CNKI databases until March 31, 2022. The primary outcome was all-cause mortality. Survival curves were depicted using the Kaplan‒Meier method and compared using the stratified log-rank test. A Cox proportional hazards model was used to estimate the prognostic factors. Results: A total of 68 patients were included, which consisted of 32 females and 36 males, with an average age of (44.5 ± 16.8) years old, ranging from 19 to 77 years. The clinical characteristics were mostly cough (49.2%), dyspnea (22.2%), hemoptysis (39.7%) and chest pain (39.7%). Kaplan‒Meier analysis showed that sex, age, hemoptysis, metastasis and treatment combining surgery with chemotherapy had a significant effect on survival. There were no effects on other outcomes. Furthermore, univariate and multivariable Cox regression analyses showed that the impact of the treatment combining surgery with chemotherapy on OS showed independent prognostic significance. Conclusion: PPC is a rare disease that lacks specific clinical features. Early diagnosis with optimal management is a significant goal. Surgery followed by adjuvant chemotherapy may be the best treatment for PPC.
Acute respiratory distress syndrome (ARDS) is a leading cause of respiratory failure, with substantial attributable morbidity and mortality. The small animal models that are currently used for ARDS do not fully manifest all of the pathological hallmarks of human patients, which hampers both the studies of disease mechanism and drug development. To examine whether the phenotypic changes of primate-like tree shrews in response to a one-hit lipopolysaccharides (LPS) injury resemble human ARDS features. LPS was administered to tree shrews through intratracheal instillation; then, the animals underwent CT or PET/CT imaging to examine the changes in the structure and function of the whole lung. The lung histology was analyzed by H&E staining and immunohistochemical staining of inflammatory cells. Results demonstrated that tree shrews exhibited an average survival time of 3-5 days after LPS insult, as well as an obvious symptom of dyspnea before death. The ratios of PaO2 to FiO2 (P/F ratio) were close to those of moderate ARDS in humans. CT imaging showed that the scope of the lung injury in tree shrews after LPS treatment were extensive. PET/CT imaging with 18F-FDG displayed an obvious inflammatory infiltration. Histological analysis detected the formation of a hyaline membrane, which is usually present in human ARDS. This study established a lung injury model with a primate-like small animal model and confirmed that they have similar features to human ARDS, which might provide a valuable tool for translational research.
Background: Escalating cases of multidrug-resistant tuberculosis (MDR-TB) pose a major challenge to global TB control efforts, necessitating innovative diagnostics to empower decentralized detection of gene mutations associated with resistance to rifampicin (RIF) and isoniazid (INH) in Mycobacterium tuberculosis (M. tuberculosis) in resource-constrained settings. Methods: Combining multiplex fluorescent PCR and Multiple Probes Melting Analysis, we identified mutations in the rpoB, katG, ahpC and inhA genes from sputum specimens. We first constructed a reference plasmid library comprising 40 prevalent mutations in the target genes’ resistance determining regions and promoters, serving as positive controls. Our assay utilizes a four-tube asymmetric PCR method with specifically designed molecular beacon probes, enabling simultaneous detection of all 40 mutations. We evaluated the assay’s effectiveness using DNA isolated from 50 clinically confirmed M. tuberculosis sputum specimens, comparing our results with those obtained from Sanger sequencing and retrospective validation involving bacteriological culture and phenotypic drug susceptibility testing (pDST). We also included the commercial Xpert MTB/RIF assay for accuracy comparison. Results: Our data demonstrated remarkable sensitivity in detecting resistance to RIF and INH, achieving values of 93.33% and 95.24%, respectively, with a specificity of 100%. The concordance between our assay and pDST was 98.00%. Furthermore, the accuracy of our assay was comparable to both Sanger sequencing and the Xpert assay. Importantly, our assay boasts a 4.2-h turnaround time and costs only $10 per test, making it an optimal choice for peripheral healthcare settings. Conclusion: These findings highlight our assay’s potential as a promising tool for rapidly, accurately, and affordably detecting MDR-TB.
A 52-year-old man was referred to our hospital for cough, fever, chest pain, and progressive dyspnea. He has worked as a full-time security staff at a community center and was in a normal state of health until 11 months prior to referral when he began experiencing cough, expectoration, a high-grade fever (up to 39.7°C), chills, and left chest pain. He visited the local hospital several times with suspected lung cancer. Bronchoscopy showed chronic inflammatory changes in his bronchi. He was given a course of antibiotics, but his fever had not subsided. The patient had visited a bamboo rat farm and consumed bamboo rat meat one year previously. He had never smoked.
The importance of the red cell distribution width (RDW)-to-platelet ratio (RPR) in clinical practice has been described in various diseases. However, the prognostic importance of the RPR in patients with acute respiratory failure (ARF) remains unclear. The aim of the present study was to investigate the association of the RPR with 30-day all-cause mortality among ARF patients in the intensive care unit (ICU). Data were obtained from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database (version 3.1). The study population was divided into different groups based on RPR quartiles (Q1–Q4). The outcome of interest was all-cause mortality within 30 days. Cox proportional regression analysis was performed to determine the relationship between the RPR and 30-day mortality, and Kaplan‒Meier (K‒M) analysis was conducted to obtain survival curves. Additionally, restricted cubic spline (RCS) analysis was utilized to determine whether there was a nonlinear correlation between the RPR (as a continuous variable) and 30-day mortality in ARF patients. Subgroup analysis was subsequently performed to determine whether the association between the RPR and 30-day mortality in ARF patients was stable across the subgroups. A total of 10,912 ARF patients were enrolled in this study. The 30-day mortality rate was 27.2%. Cox proportional regression analysis revealed that an elevated RPR was associated with an increased risk of 30-day mortality in ARF patients. Furthermore, K‒M survival analyses revealed that patients with higher RPR levels demonstrated significantly higher all-cause mortality rates within 30 days of admission than patients with lower RPRs. The RCS model illustrated the linear relationship between a higher RPR and increased risk of mortality in this specific patient population. The final subgroup analysis indicated no significant interaction effect of the RPR in most of the subgroups. This study demonstrated that RPR levels were significantly associated with short-term prognosis in patients with ARF and that a high RPR could serve as an independent predictor of all-cause mortality at 30 days in patients with ARF.
Background: With the rapid development of medical technology and the emphasis on early lung cancer screening, the detection rate of multiple primary lung cancer (MPLC) has increased in recent years. However, the prognostic determinants and clinical characteristics of patients with MPLC remain poorly characterized. Objective: This study aimed to develop and validate a nomogram for predicting overall survival (OS) in patients with MPLC using data from the Surveillance, Epidemiology, and End Results database. Methods: This study was reported in accordance with the TRIPOD (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis) guidelines. A cohort of 4177 patients with MPLC (2007‐2015) was obtained from the Surveillance, Epidemiology, and End Results database. The patients were randomly divided into training (n=2923) and validation (n=1254) cohorts at a 7:3 ratio. Backward stepwise Cox regression identified 11 independent risk factors, which were integrated into a nomogram predicting 3-, 5-, and 8-year OS rates. Results: The nomogram demonstrated superior discriminative ability compared to the American Joint Committee on Cancer staging system, with higher area under the receiver operating characteristic curve values for 3-, 5-, and 8-year OS predictions in both cohorts (training cohort: 0.743, 0.751, and 0.759, respectively; validation cohort: 0.737, 0.734, and 0.695, respectively). Calibration curves and decision curve analysis confirmed its clinical utility. Conclusions: This study establishes a validated nomogram incorporating clinical and socioeconomic variables to optimize prognostic assessment and personalized treatment planning for patients with MPLC.